Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Neuro Oncology 2019

Welcome message

Dear Colleagues,

Conference Series extends its welcome to the conference 5th International Conference on Neuro-Oncology and Brain Tumor during August 14-15, 2019 Tokyo, Japan with a theme “Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor”. Conference Series through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Conference Series Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members. Neuro-Oncology 2019, Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. Neuro-Oncology 2019 is a perfect platform to find out how Neuro-Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Neuro-Oncology and medical sectors.

About Conference


The Conference Neuro-oncology 2019 is accredited with CPD credits

We are happy to welcome you to the official website of 5th International Conference on Neuro-Oncology and Brain Tumor during August 14-15, 2019 Tokyo, Japan with the theme of "Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor" which covers wide range of critically important sessions. It’s a platform to bring all the neurooncologists and Neuroscientists together to share their experiences it’s the amalgam of scientific research as well as innovative ideas.

Overview of Neuro-oncology and Brain tumour:

An important area of clinical Neuro-Oncology and Brain Tumour that is increasingly relevant as survivorship increases and as patients experience potential morbidities associated with new therapies. Neuro-Oncology is the study of Brain and Spinal cord neoplasms, many of which are   (at least eventually) very dangerous and life-threatening (Astrocytoma, Glioma, Glioblastoma multiforme, Ependymoma, Pontine Glioma, and Brain stem tumors are among the many examples of these). Among the Malignant Brain cancers, Gliomas of the brainstem and pons, Glioblastoma multiform, and high-grade (highly anaplastic) Astrocytoma are among the worst.

Geographically market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Neuro Oncology (i.e. on Brain Cancer and CNS Tumors) will be more than double to $ 623 Million by 2020. A major part of research is going on the top Universities on across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.

Conference Highlights:

Neuro-Oncology

Neurological Disorders

Brain Tumor

Advancements in Neuro-Oncology

Neoplasms

Neurosurgical Oncology

Metastatic Cancer

Advancements in Brain Tumor

Neuro Pharmacology

Brain Tumor Diagnosis

Gangliocytoma

Neuroradiology

Choroid Plexus Tumor

Immunotherapy

Brainstem Glioma

Neuroimaging

Neuropsychology 

Medical Treatment of Metastatic Cancer to the Nervous System

Para Neoplastic Neurological Syndrome

Treatment of cancer related complications

Who Should Attend?

  • Directors
  • Head of Department
  • Professors
  • Industrial Researchers
  • Neuro-oncologist
  • Radiation Oncologists
  • Oncologists
  • Neuropediatricians
  • Neurophysiologists
  • Neurosurgeons
  • Neurologist
  • Neuroradiologist
  • Neuro-Pathologists
  • Rehabilitation Specialists
  • Nurses
  • Neuroscience Researchers and Students from academia in the research of Neuro-oncology, Neurooncology Associations, Brain tumour societies

Target Audience:

Academia: 65%

Industry: 25%

Others: 10%

Why to attend?

5th International Conference on Neuro-Oncology and Brain Tumor tends to bring together worldwide distinguished academics in the field of Neuro-oncologist, Oncologist, Radiation Oncologist, Medical Oncologists, Neuropharmacology, Neurology, Neuropediatricians, Pediatric Oncologists, Neurosurgeons, Neurophysiologists,  Neuroscience  Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of cancer to Patients. Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery.

The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

For more details please visit: https://neurooncology.conferenceseries.com/

 Who should sponsor/exhibit:

  • Basic and Translational Laboratory Researchers       
  • Hospitals
  • Educational Institutes
  • Research Centers
  • Charitable Foundations focused on funding research, advocating for and supporting the needs

Benefits of attending:

  • Networking Opportunities, Grow Your Professional Network
  • Build Your Knowledge Base
  • Expand Your Resources
  • Meet Experts & Influencers Face to Face
  • Learning in a New Space
  • Break Out of Your Comfort Zone
  • New Tips & Tactics
  • Greater Focus
  • The Serendipity of the Random Workshop

Sessions/Tracks

It is our pleasure to invite you for the conference “5th International Conference on Neuro-Oncology and Brain Tumor” going to be held during August 14-15, 2019 Tokyo, Japan. The main theme of our conference is “Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor “which covers wide range of critically important sessions.

Around 1 billion people, nearly one in six of the world’s population, suffer from Neurological disorders like Multiple Sclerosis, Alzheimer, Parkinson Disease, Stroke, Epilepsy, Migraine, Brain injuries and Neuro-infections.

The World Health Organization estimated that Neurological disorders affect up to one Billion people Worldwide. In fact, Neurological diseases make up 11% of the World’s disease burden, not including mental health and addiction disorders.

Track 1:  Neuro-Oncology

The Central Nervous System is denounced to various malevolent disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Neurodegenerative disease and Imaging agents to CNS neurofibroma. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures.

Global Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2011-2015. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 2:  Brain Tumor

Brain Tumor occurs when abnormal cells form within the brain. The symptoms of Brain stem tumors vary greatly and can include AtaxiaCranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumor is inherently serious and life-threatening because of its invasive and infiltrative character in the limited space of the Intracranial Cavity.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 3:  Neoplasms

Neoplasm is an abnormal growth of tissue, which forms a mass that commonly referred to as a Tumor. Neoplasm can be caused by an Abnormal Proliferation of Tissues, that which can be caused by Genetic mutations. Not all types of Neoplasms cause a tumorous overgrowth of tissue. Malignant Neoplasms derived from epithelial cells are called Carcinomas.

Relevant  Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | National Academies

Track 4:  Metastatic Cancer

Metastasis is defined as the process by which Cancer cells spread to other parts of the body. Metastatic Cancer is called as Stage IV cancer among many stages of it. Metastasis is one of the hallmarks of cancer distinguishing it from benign tumors. And it can spread to distant parts of the body.

Relevant Conferences: Neurology Conferences | Neurology Congress | Neurology Events | Meetings on Neurology | 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam, Netherlands; Annual Congress on Neurology & Neuroscience March 14-15, 2019 Paris, France; 24th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France

Related Associations and Societies: American Board of School Neuropsychology (ABSNP), American Clinical Neurophysiology Society (ACNS), American College of Neuropsychopharmacology (ACNP), American Neurological Association (ANA), Association for the Neurologically Disabled of Canada (AND Canada) - Canada (CA), Association of British Neurologists (ABN) - United Kingdom (UK), American Neuropsychiatric Association (ANPA), American Neurotology Society(ANS), Canadian Association of Neuroscience Nurses (CANN) - Canada (CA), Canadian Congress of Neurological Sciences (CCNS) - Canada (CA), American Psychological Association(APA Division 40) - Clinical NeuropsychologyAmerican Society for Experimental NeuroTherapeutics (ASENT).

Track 5:  Meningioma

Meningioma is referred to as slow growing Brain tumors, but their origin is not from the Brain tissue. Meningiomas are often benign tumors arising from the Arachnoidal cells of Meninges of the brain and spinal cord. Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching a large size. They represent about one-third of all Primary Brain Tumors and occur most frequently in middle-aged women.

Relevant  Conferences: Neurology  Conferences | Neurology Congress | Neuroscience conferences | Conferences in Europe | 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5th World Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: American Society for Neural Transplantation and Repair (ASNTR), American Society for Neurochemistry (ASN), American Society of Electroneurodiagnostic Technologists(ASET), American Society of Interventional & Therapeutic Neuroradiology (ASITN), American Society of Neuroimaging (ASN), Canadian Association of Neuroscience Nurses (CANN) - Canada (CA), Canadian Congress of Neurological Sciences (CCNS) - Canada (CA), American Society of Neurophysiological Monitoring (ASNM), American Society of Interventional & Therapeutic Neuroradiology (ASITN), American Society of Neuroimaging (ASN), American Society of Neurophysiological Monitoring (ASNM), American Society of Neurorehabilitation(ASNR), American Society of Neuroradiology (ASNR).

Track 6:  Gangliocytomas

Gangliocytomas are rare indolent CNS tumours which are made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lack neoplastic glial cells. Treatment involves surgical removal of the tumor. These are Neuroepithelial Tumors which line the ventricles of the brain and produces Cerebrospinal fluid.

Relevant  Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 7:  Choroid Plexus Tumor

Choroid Plexus Tumor arises from Brain tissue that invades nearby tissue and spread widely via the cerebrospinal fluid. Like other brain tumors, choroid plexus tumors are also “graded.” Like other Brain Tumors, Choroid Plexus Tumors are also “graded.” Choroid Plexus Neoplasms are rare, Intraventricular, Primary Central Nervous System (CNS) tumors derived from Choroid Plexus Epithelium that are seen predominantly in children.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 8:  Brainstem Glioma

A Brainstem glioma is an aggressive and dangerous Cancerous Glioma Tumor in the brainstem which starts in the Brain or Spinal cord tissue and typically spread throughout the Nervous System. It is more diagnosed in children and young adults under the age of twenty. Symptoms of Brainstem glioma can develop slowly and subtly and may go unnoticed for months. A sudden onset of symptoms tends to occur with more rapidly growing, high-grade tumors. In other cases, the symptoms may arise abruptly. Unlike most Brain tumors, Brainstem Glioma is not often treated with Neurosurgery due to complications in vital parts of the Brain. Without treatment, the life expectancy is typically a few months from the time of diagnosis.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 9:  Neuropsychology and Neuropsychiatry

The Psychosocial and Neurocognitive functioning of several cancer patients and survivors deleteriously affected by various treatments of Malignant tumors such as ChemotherapyRadiotherapy and Hormonal therapy. Oncology researchers and Clinicians are increasingly Cognizant of the negative effects of Cancer and its treatments on the Brain and its mental processes and Cognitive outcomes.

Neuropsychology in Cancer features the current findings on the Neuropsychological effects of the Cancers and their treatments along with the most promising Neuropsychological and behavioural health interventions available to mitigate these deficits.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 10:  Para Neoplastic Neurological Syndrome

Para Neoplastic Neurological Syndromes (PNS) are defined as the remote effects of cancer on the Nervous System. They are due to the presence of Cancer and exclusion of other known causes of the Neurological symptoms, but this criterion does not separate “true” PNS from Neurological syndromes that are coincidental with a Cancer.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | National Academies

Track 11:   Novel Therapies in Neuro-Oncology

The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, Multidisciplinary effort to develop new standardized response criteria for Clinical trials in Brain tumors. The Surgery Working Group of RANO identified surgically related End-point evaluation problems that were not addressed in the original Macdonald criteria. Macdonald criteria led to the initiation of an International effort in Neurooncology to develop Novel Response and Progression Assessment Criteria.

Relevant  Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 12:   Advancements in Neuro-Oncology

In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction in Radiation-associated late toxicity, while in selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumours Prognostic Biological markers have been identified that are undergoing prospective evaluation. In infants the use of post-surgical chemotherapy alone may allow the postponing of Radiotherapy in selected cases. For patients with localized Medulloblastomas a new standard treatment is emerging that uses reduced-dose Craniospinal Radiotherapy followed by Platinum-based chemotherapy, while in Supratentorial primitive Neuroectodermal tumours future treatment will be aimed at improving local control.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | National Academies

Track 13:   Neurosurgical Oncology

Neurosurgery is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance common Neuro surgeries are skull base surgeryImage Guided SurgeryLaser SurgerySpinal Neurosurgery and Neuro surgical treatment.

The Global Neurosurgery market is expected to raise 11.71% over the session of 2014-2019. Neurosurgery session includes Image Guided Surgery, Laser Surgery, Surgical operation for brain fibro adenoma, Spinal Neurosurgery, Skull base surgery, Neuro surgical treatment, Geriatric Neurosurgery, latest innovations and techniques.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 14:   Advancements in Brain Tumor

The upcoming implementation of a Neurosurgical ablation device that provides controlled therapy for brain lesions those are difficult to reach and treat. This tool, will allow us to introduce the probe into the tumor and destroy it without having to perform a Surgical Operation or Craniotomy.

Recent advances have made treatment for brain tumors much safer and more successful. Some of these newer techniques include:

•Antiseizure/Antiepileptic Drugs (AEDs)

•Steroids

•Surgery: The goal of surgery in the treatment of metastasis is to maximally remove tumor while leaving patients with good function

•Radiosurgery: A non-invasive technique that delivers numerous narrow, precisely aimed, highly focused beams of ionizing radiation that converge at a specific point.

•Radiation therapy: X-rays and other forms of radiation can destroy tumor cells or delay tumor   growth.

•Chemotherapy: The use of drugs to kill rapidly dividing cells. It can be taken orally or intravenously.

•Targeted therapy: The focus on a specific element of a cell, such as molecules or pathways required for cell growth, in order to use them as a target.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 15:   Brain Tumor Diagnosis

The following are the steps involved in Brain Tumor Diagnosis;

  •  A neurological exam: A neurological exam may include, among other things, checking your vision,            hearing, balance, coordination, strength and reflexes. Difficulty in one or more areas may provide clues        about the part of your brain that could be affected by a brain tumor.
  •   Imaging testsMagnetic Resonance Imaging (MRI) is commonly used to help diagnose brain tumors.           In some cases a dye may be injected through a vein in your arm during your MRI study.

   A number of specialized MRI scan components — including functional MRI, perfusion MRI and Magnetic Resonance Spectroscopy

Other imaging tests may include Computerized Tomography (CT) scan and Positron Emission Tomography (PET).

  • Tests to find cancer in other parts of your body: If it's suspected that your Brain tumor may be a result of Cancer that has spread from another area of your body, your doctor may recommend tests and procedures to determine where the cancer originated. One example might be a CT scan of the chest to look for signs of Lung Cancer.
  • Collecting and testing a sample of abnormal tissue (biopsy): A Biopsy can be performed as part of an operation to remove the Brain tumor, or a Biopsy can be performed using a needle.

A stereotactic needle biopsy may be done for brain tumors in hard to reach areas or very sensitive areas within your brain that might be damaged by a more extensive operation. Your Neurosurgeon drills a small hole into your skull. A thin needle is then inserted through the hole. Tissue is removed using the needle, which is frequently guided by CT or MRI scanning.

The Biopsy sample is then viewed under a microscope to determine if it is cancerous or benign. This information is critical to establish a diagnosis and prognosis and, most importantly, in guiding treatment.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | National Academies

Track 16:   Neuroradiology

Neuroradiology uses primary imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) to focus on Endovascular or minimally invasive diagnosis and characterization of abnormalities of the Central Nervous System or head and neck lesions such as Tumors, Aneurysms, Vascular malformations, or Stroke. It involves different types of Imaging Studies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) for characterization of various Neurological disorders.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 17:   Neuroimmunology

The Immunotherapy treats the Immune system in Injury and repair during wide range of Neurological disorders, Inflammatory and Autoimmune Diseases of the Nervous system such as Multiple Sclerosis (MS) and Neuromyelitis Optical (NMO) and several Brain Tumor conditions. There were numerous Radiological studies to improve Diagnosis and treatment of these diseases. The main focus is to develop the so-called Neuroprotective (nerve cell protecting) treatment approaching and establishing Modern examination procedures such as MRI (Magnetic Resonance Imaging), OCT (Optical Coherence Tomography) and Motion Analysis.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 18:   Neuroimaging

Neuroimaging is the Mapping of human Brain using functional Magnetic Resonance Imaging (fMRI). It determines how difference and change in Cerebral structure, complexly relates to Behavior and Cognition at Multiple levels of Analysis. It includes Multimodality imaging like CT, MRI, PET, to offer most precise information noninvasively, on type of the Tumor and grade; it also guides therapeutic choices and also assesses the effects of therapy

Neuroimaging development, testing, and implementation of advanced MRI and PET Imaging biomarkers for the characterization of Brain Tumor biology and response evaluation in Clinical trials able to detect the biological behaviour of Brain Tumor more accurately.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | National Academies

Track 19:    Medical Treatment of Metastatic Cancer to the Nervous System

A Metastatic Cancer is one which has spread from the primary site of origin into different area of the body. That occurs in about one-fourth of all cancers that spread through the body.  Treatment for Metastatic Cancer aims to slow the growth or spread of the Cancer. Treatment depends on the type of cancer, where it started, the size and location of the Metastasis, and other factors.

The primary tumor may be found by examining tumor tissues from the brain. Tests may include; Cerebral Angiography, Mammogram, Chest x-ray, CT scans of the Chest, Abdomen, and Pelvis to find the original tumor site, MRI of the Brain, Lumbar puncture, EEG.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Track 20:   Treatment of cancer related complications

Occurrence of Cancer related complications are seen during Chemotherapy because the dividing blood cells in bone marrow are also prone to damage from medications used in treatment also many of these side effects can be attributed to low blood counts. In rare cases, some Chemotherapy drugs can cause Heart damage or trigger another cancer such as Leukaemia. Some complications seen are

  •         Infection
  •         Fatigue
  •         Bruising
  •         Bleeding
  •         Sleep disturbances

Preventive measures should start before cancer therapy begins, reducing the occurrence of further problems brought about by different treatment modalities.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Société Française de Neurologie | Georgian Society of Neurologists

Market Analysis

Neuro-oncology 2019 welcomes attendees, presenters, and exhibitors from all over the world to Tokyo, Japan. We are delighted to invite you all to attend and register for the 5th International Conference on Neuro-Oncology and Brain Tumor which is going to be held during August 14-15, 2019 Tokyo, Japan.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuro-oncology 2019, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Neuro-oncology 2019 organizing committee look forward to meeting you in Tokyo, Japan.

For more details please visithttps://neurooncology.conferenceseries.com/

Importance and Scope:

5th International Conference on Neuro-Oncology and Brain Tumor is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Neuroscience.

Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Neuroscience and its allied areas.

Why Tokyo?

Tokyo is Japan’s capital and the largest metropolitan area in the world. It is also one of Japan’s 47 prefectures, consisting of 23 central city wards and multiple cities, towns, and villages west of the city centre. The Izu and Ogasawara Islands are also part of Tokyo. Prior to 1868, Tokyo was known as Edo. A small castle town in the 16th century, Edo became Japan’s political centre in 1603 when Tokugawa Ieyasu established his feudal government there. A few decades later, Edo had grown into one of the world’s most populous cities. With the Meiji Restoration of 1868, the emperor and capital moved from Kyoto to Edo, which was renamed Tokyo (“Eastern Capital”).World’s highest Skywalk- the Tokyo Sky Tree is the tallest free-standing tower in the world, measuring 634m. The observation deck at 450m is the world’s highest skywalk and offers panoramic views of the city. Tokyo is a fascinating city, where the latest trends and the oldest traditions meet. From ancient cherry-blossom festivals to the vibrant Harajuku neighborhood. Tokyo offers a seemingly unlimited choice of shopping, entertainment, culture, and dining to its visitors. The city’s history can be appreciated in districts such as Asakusa, and in many excellent museums, historic temples, and gardens. Contrary to common perception, Tokyo also offers a number of attractive green spaces in the city centre and within relatively short train rides at its outskirts.

Conference Highlights:

  • Neurologist
  • Neuro Oncologist
  • Psychiatrist
  • Pharmaceutical company
  • Research scholars
  • Pathologist
  • Diagnostics companies
  • Neuroscience Professors
  • Neuroradiologists
  • Researchers and others
  • Academicians
  • Neuro Pharmacologists
  • Research and Development Department.
  • Laboratory Professionals
  • Ph.D. Students
  • Adult Medical Oncology and Hematology
  • Pediatric Oncology and Hematology
  • Neuro-Oncology
  • Neurology
  • Neurosurgery
  • Radiation Oncology
  • Neuropathology and others

Why to attend???

Neuro-oncology and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders.

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://neurooncology.conferenceseries.com/sponsors.php

 Major Associations around the Globe

  • Neuropathy Association
  • The brain & behaviour research foundation
  • Alzheimer's Association
  • American Academy of Neurology
  • European Neurological Societies
  • World Federation of Neurology
  • Spanish Society of Neurology
  • Major Neurological Associations in Italy
  • Hilarescere Foundation in Italy
  • Italian MS society in Italy   
  • Southern Clinical Neurological Society
  • ESNR European Society of Neuroradiology
  • Vision sciences society

Around 20 associations of Neurology are there in Germany

  • German Neurological Society
  • Society Of Neuroscience
  • European Paediatric Neurology Society
  • German Society Of Neurosurgery
  • Munich Canter Of Neuroscience
  • International Society Of Neurochemistry
  • German Association For Psychiatry, Psychotherapy And Psychosomatics
  • German Neurological Society
  • German Stroke Society
  • European Paediatric Neurology Society
  • Einstein Center for Neurosciences (ECN)
  • Bernstein Center for Computational Neuroscience
  • The World Society for Stereotactic and Functional Neurosurgery
  • Bernstein Center for Computational Neuroscience
  • Society for Neuroeconomics
  • European Neurological Society
  • The European Association Of Neurosurgicalsocieties (EANS)

There are around 10 Neuroscience associations in Tokyo, Japan

  • German Neurological Society
  • German Stroke Society
  • European Paediatric Neurology Society
  • Einstein Center for Neurosciences (ECN)
  • Bernstein Center for Computational Neuroscience
  • The World Society for Stereotactic and Functional Neurosurgery
  • Bernstein Center for Computational Neuroscience
  • Society for Neuroeconomics
  • European Neurological Society
  • The European Association of Neurosurgicalsocieties (EANS)

Target Audience:

Directors, Neurologist, Neurosurgeons, Psychiatrist, head of department, Professors and Students from Academia in the research of Neuroscience.

Target Audience:

Academia 60%

Industry   30%

Others       10%

Top universities globally working in the field of Neuroscience

  • Dalhousie University
  • Leiden University- Neither land
  • Temple University USA
  • University Oklahoma
  • Boston Coll USA
  • Florida International University
  • University California – Davis
  • University Sheffield
  • University Manchester
  • University of Nottingham
  • Cardiff University
  •  University of Toronto – Canada

Top universities in Japan which are working in the field of Neurology

  • University of Tokyo
  • Kyoto University
  • Osaka University
  • Tokyo Medical and Dental University
  • Tohoku University
  • Keio University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Okayama Unive rsity

  Top Universities in and around Japan which are working in the field of Neurology

  • Bernstein Center for Computational Neuroscience
  • Center for Cognitive Neuroscience
  • Berlin School of Mind and Brain
  • Charite - Medical University of Humboldt-Universität zu
  • Einstein Center for Neurosciences

Hospitals Associated with Neuroscience Research

All around the globe there are 6000 hospitals working on Neurology

Some of them among them are:

  • Johns Hopkins Hospital
  • World Brain Center Hospital
  • Duke University Hospital
  • Edward Hospital
  • Munson Medical Center

There are around 120 hospitals in Japan exclusively working on Neurology

  • Aichi Saiseikai Hospital 
  • Chubu Rosai Hospital 
  • Holy Spirit Hospital
  • Japan Community Health care Organization Chukyo Hospital 
  • Japanese Red Cross Nagoya Daiichi Hospital 
  • Japanese Red Cross Nagoya Daini Hospital 
  • Meijo Hospital 
  • Meitetsu Hospital 
  • Nagoya City East Medical Center 
  • Nagoya City University Hospital 
  • Nagoya City West Medical Center
  • Nagoya Ekisaikai Hospital 
  • Nagoya Memorial Hospital
  • Nagoya University Hospital 
  • National Hospital Organization Higashi Nagoya National Hospital 
  • National Hospital Organization Nagoya Medical Center 

Around 20 hospitals are there in Tokyo, Japan

  • Nagoya City West Medical Center
  • Nagoya Ekisaikai Hospital 
  • Nagoya Memorial Hospital
  • Nagoya University Hospital 
  • National Hospital Organization Higashi Nagoya National Hospital 

Past Conference Report

Neuro Oncology 2018

3rd International Conference on Neuro-Oncology and Brain Tumor was organized during September 14-15, 2018, in Singapore, with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at Neuro Oncology 2018, a global platform to discuss various important aspects of Neurology.

There are infinite reasons to extend our gratitude to you for making the Neuro Oncology 2018 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Neuro Oncology 2018 a new heights in the field of Neuroscience.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 15 countries, who have driven this event into the path of success.   

The conference was organized around the theme “Innovative Techniques and Advancements in Neuro-Oncology”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological disorders and Stroke with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:  Lissy Ann Puno from Singapore, Mitusha Verma from India, Sangeeta Mudaliar from India, Radu Mutihac from Romania, Walter Bini, from UAE, Minoo Sharbafshaaer from Iran, J. Harini Christopher from India, Satu Pihlaja from Finland.

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurological disorders and Stroke through their fabulous presentations at the podium of Neuro-oncology 2018.   

Conference series llc LTD offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners, sponsors and Editorial Board Members of Journal of Neurology, Journal of Brain Disorders & Therapy and  Journal of Brain Tumors & Neurooncology who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members Dr. TANJU UÇAR, University of Akdeniz, University of Akdeniz, Michael Coroneos, Bond University, Australia, KrupaTorne, Surya Children’s Hospital, India, Elixena Lopez Savon, Hospital Juan Manuel Marquez La Habana, Cuba.

So as a continuation of Neuro Oncology 2018, we would like to heartily invite you to our upcoming 5rd International Conference on Neuro-Oncology and Brain Tumor during August 14-15, 2019 Tokyo, Japan.

For 2019 we are expanding our focus towards all aspects of Neurological Disorders and Stroke Re­search findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurological Disorders and Stroke.

Your expertise and knowledge in the area of Neurological Disorders and Stroke will provide an oppor­tunity to discuss and respond to a series of questions about the status of advanced Neurological Disorders and Stroke therapeutics.

Stroke is ranked as the second leading cause of death in the Dubai. In the Middle East and North Af­rica, stroke is emerging as a major health problem, with death rate from it will be double by 2030. In 2013 alone, U.A.E. healthcare expenditures reached an estimate $ 16.8. The healthcare market of the UAE is expected to expand at a CAGR of over 16% during 2011-2014 on back of neurological disorders. About $ 177.5 million revenue generated from medical tourism in 2012, which may rise to $ 710 million by 2020. FDA submitted drug market report on central nervous system disorders which is estimated $78 billion in 2010 and to reach nearly $81.8 billion by 2015. The market survey forecast of neurological disorders is more than $500 billion per year and also the cost of stroke care is expensive too.

We would like to organize this conference with your support to gather all the Neurological Disorders and Stroke researchers in an single platform, hope we will be honoured with your support to organize Neuro-oncology 2019 in a grand level, your support will be the key of success for our next year conference.

We look forward to see your benign presence with active contribution and support to make this event successful once more.

Once again it’s our pleasure to welcome you to our upcoming 5thInternational Conference on Neuro-Oncology and Brain Tumor during September 14-15, 2018 Singapore.

Know more at: https://neurooncology.conferenceseries.com/

Let us meet again in Tokyo, Japan


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date August 14-15, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Imaging and Interventional Radiology Journal of Brain Tumors & Neurooncology Journal of Cancer Science & Therapy Journal of Clinical & Experimental Oncology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by